BD (Becton, Dickinson and Company), has received FDA 510(k) clearance for the BD Vacutainer Barricor plasma blood collection tube (BD Barricor).

BD (Becton, Dickinson and Company), announced that it received FDA 510(k) clearance for the BD Vacutainer Barricor plasma blood collection tube (BD Barricor), the next generation blood collection and separation technology designed to improve sample quality, help clinicians receive test results faster, and ultimately improve patient care and clinical efficiency. BD Barricor is a single-use, plastic, evacuated tube used to efficiently obtain high-quality plasma for in vitro diagnostic use. The BD Barricor tube uses a novel mechanical separation technology to obtain plasma from whole blood samples, replacing the need for gel tubes. The BD Barricor tube is the first to leverage this technology in a clinical setting. The revolutionary mechanical separator technology reduces centrifugation time from 10 minutes to three minutes, compared to leading gel tubes, and reduces cellular contamination by 50 to 65 percent compared to leading plasma gel tubes.

The BD Barricor has received a CE Mark and is launched in Europe in March 2016.